Iron pill associated duodenitis: a less recognised clinical entity

Authors

  • Jayjit Guha Department of Family Medicine, Sir Ganga Ram Hospital, Delhi, India
  • Vinus Taneja Department of Internal Medicine, Sir Ganga Ram Hospital, Delhi, India
  • Pooja Khosla Department of Internal Medicine, Sir Ganga Ram Hospital, Delhi, India
  • Rishikesh Dessai Department of Internal Medicine, Sir Ganga Ram Hospital, Delhi, India
  • Manuj Sondhi Department of Internal Medicine, Sir Ganga Ram Hospital, Delhi, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20240236

Keywords:

Anaemia, Iron deficiency, Duodenitis, Ferrous sulphate

Abstract

Iron supplementation is a widely prescribed treatment for anemia, but its association with gastrointestinal complications, specifically duodenitis, remains inadequately acknowledged in clinical practice. One of the common oral iron preparations to treat iron deficiency anemia is ferrous sulphate. Iron preparations have been known to cause gastric side effects, including gastritis and duodenitis. This case report explores the emerging concern of iron pill-associated duodenitis, shedding light on the potential adverse effects of oral iron supplementation on the duodenal mucosa. Existing literature and clinical cases are reviewed to highlight the connection between iron pill consumption and duodenal inflammation. From asymptomatic cases to severe symptoms like abdominal pain and gastrointestinal bleeding, the clinical spectrum is diverse. Histopathological analysis of endoscopic biopsies reveals characteristic features of duodenitis linked with iron deposits, raising concerns about long-term consequences. In conclusion, this case underscores the significance of recognizing iron pill-associated duodenitis as a distinct clinical entity, necessitating further investigation for optimized patient care and the safe administration of iron supplements in managing anemia.

 

References

Smith ER, Cai MMX, McMahon LP. The impact of a new oral iron supplement on markers of iron status and functional outcomes in women with iron deficiency anemia: A randomized controlled trial. Blood. 2017;130(1):2233.

Patel N, Shah A, Panchal H. Iron Pill Gastritis: An underdiagnosed entity. Case Rep Gastrointest Med. 2019;2019:3704514.

Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011;4(3):177-84.

Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication. Am J Surg Pathol. 1999;23:1241-7.

Cancelo HMJ, Castelo BC, Palacios S, Haya PJ, Ciria RM, Manasanch J, et al. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin. 2013;29:291-303.

Jeung J, Ashour S, Fuller L. Iron pill-induced duodenitis: A distinct pattern of duodenal mucosal injury in a patient with a duodenal mass. Pathol Res Pract. 2020;216(5):152916.

Haig A, Driman DK. Iron-induced mucosal injury to the upper gastrointestinal tract. Histopathology 2006; 48:808-12.

Eckstein RP, Symons P. Iron tablets cause histolopathogically distinct lesions in mucosal biopsies of the stomach and oesophagus. Pathology. 1996;28:142-5.

Kaye P, Abdulla K, Wood J. Iron induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology. 2008;53:311-7.

Marginean EC, Bennick M, Cyzck J, Robert ME, Jain D. Gastric siderosis patterns and significance. Am J Surg Pathol. 2006;30:514-20.

Abumoawad A, Venu M, Huang L, Ding X. Pseudomelanosis duodeni: a short review. Am J Dig Dis Nutr. 2015;2:41-5.

Downloads

Published

2024-01-30

How to Cite

Guha, J., Taneja, V., Khosla, P., Dessai, R., & Sondhi, M. (2024). Iron pill associated duodenitis: a less recognised clinical entity. International Journal of Research in Medical Sciences, 12(2), 601–603. https://doi.org/10.18203/2320-6012.ijrms20240236

Issue

Section

Case Reports